NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-173-2020-0-CA-01 T CELL RECEPTORS RECOGNIZING R273C OR Y220C MUTATIONS IN P53 CA National Stage 3191186 Pending
NCI E-167-2019-0-CA-01 T CELL PHENOTYPES ASSOCIATED WITH RESPONSE TO ADOPTIVE CELL THERAPY CA National Stage 3191211 Pending
NCATS E-014-2022-0-US-02 HYDROXYNORKETAMINE COMPOUNDS AND METHODS OF USE THEREOF US National Stage 18/043,163 Pending
NCI E-149-2015-0-US-02 METHODS OF ISOLATING T CELLS AND T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION FROM PERIPHERAL BLOOD US CON 18/174,928 Pending
NCI E-050-2014-0-US-02 CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS USING A VLP-REPLICON US DIV 18/174,013 12049639 Issued PDF
NCI E-128-2022-0-US-01 Improving Heart Function Following Myocardial Infarction Using Anti-TEM8/ANTXR1 Antibodies US 63/448,198 Abandoned
NHLBI E-126-2020-0-US-02 Methods To Produce Very Long Chain Fatty Acids (VLCFA) US National Stage 18/042,743 Pending
NIAID E-288-2016-0-US-02 BIOMARKERS AND IMMUNOGENIC COMPOSITIONS FOR FILARIAL PARASITES US DIV 18/173,288 Pending
NIEHS E-022-2023-0-US-01 MUTANT ARA H 2 AND ARA H 6 PROTEINS AND USES THEREOF US 63/486,570 Expired
NCI E-245-2023-0-US-01 Liquid Biopsy to Detect Cancer Early and Sensitively in Patients with Neurofibromatosis Type 1 US 63/486,555 Expired
NCI E-173-2020-0-SG-01 T CELL RECEPTORS RECOGNIZING R273C OR Y220C MUTATIONS IN P53 SG National Stage 11202301360P Pending
NCI E-087-2015-1-US-04 METHODS AND COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE USING
CONSERVED ELEMENT CONSTRUCTS 		US CON 18/171,804 Pending
NIAID E-052-2017-4-CN-03 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection CN DIV 202310147287.X Pending
NCI E-167-2019-0-AU-01 T CELL PHENOTYPES ASSOCIATED WITH RESPONSE TO ADOPTIVE CELL THERAPY AU National Stage 2021341969 Pending
NCI E-109-2020-0-JP-01 PREFERENTIAL GENERATION OF iPSC CARRYING ANTIGEN SPECIFIC TCRs FROM TUMOR INFILTRATING LYMPHOCYTES JP National Stage 2023-512482 Pending
NHLBI E-126-2020-0-IL-01 Methods To Produce Very Long Chain Fatty Acids (VLCFA) IL National Stage 2068-07-30 Pending
NINDS E-146-2016-1-US-02 SELECTIVE D3 DOPAMINE RECEPTOR AGONISTS AND METHODS OF THEIR USE US CON 18/111,241 12145922 Issued PDF
NCI E-172-2020-0-CN-01 HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION CN National Stage 202180050745.7 Pending
NICHD E-018-2022-0-PC-01 METHODS OF TREATING NEONATAL LIVER DISEASE PCT PCT PCT/US2023/062843 Expired
NCATS E-116-2016-0-US-12 CRYSTAL FORMS AND METHODS OF SYNTHESIS OF (2R, 6R)-HYDROXYNORKETAMINE AND (2S, 6,)-HYDROXYNORKETAMINE US CON 18/170,048 Pending
NCI E-075-2020-0-US-06 SYSTEMS, METHODS, AND DEVICES FOR EX VIVO ANALYSIS OF RESECTED TISSUE SAMPLES US National Stage 17/910,911 Pending
NCI E-163-2020-0-AU-01 LZK-TARGETING DEGRADERS AND METHODS OF USE AU National Stage 2021336300 Pending
NCI E-025-2022-0-PC-01 CD28 HINGE AND TRANSMEMBRANE CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GPC2 AND USE THEREOF PCT PCT PCT/US2023/062525 Expired
NCI E-172-2020-0-KR-01 HLA Class-II Restricted DRB1*01:01 T-cell Receptors Against The RASG12V Mutation KR National Stage 20237005176 Pending
NCI E-183-2017-0-JP-01 ANTI-B-CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTORS WITH HUMAN DOMAINS JP DIV 2023-020373 Issued
NIAAA E-282-2012-0-US-02 CANNABINOID RECEPTOR MEDIATING COMPOUNDS US CON 18/108,264 11939297 Issued PDF
NEI E-195-2020-0-US-03 SAMPLE PREPARATION AND VIRAL DETECTION METHODS US National Stage 18/041,295 Pending
NCI E-109-2020-0-US-02 PREFERENTIAL GENERATION OF iPSC CARRYING ANTIGEN SPECIFIC TCRs FROM TUMOR INFILTRATING LYMPHOCYTES US National Stage 18/020,823 Pending
NCATS E-200-2020-0-US-04 REAL-TIME CELLULAR THERMAL SHIFT ASSAY (RT-CETSA) FOR RESEARCH AND DRUG DISCOVERY US National Stage 18/020,843 Pending
NCI E-172-2020-0-EP-01 HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION EP National Stage 21752355.4 Pending
NCI E-165-2020-0-EP-01 HLA Class-II Restricted DRB T-cell Receptors Against The RASG12D Mutation EP National Stage 21751702.8 Pending
NIAID E-047-2022-0-PC-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses PCT PCT PCT/US2023/062324 Expired
NCI E-181-2021-0-PC-01 COMBINATION IMMUNOTHERAPY FOR TREATING CANCER PCT PCT PCT/US2023/062288 Expired
NIAID E-047-2022-0-SG-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses SG National Stage 11202405288Y Pending
NCI E-107-2020-0-EP-01 IGG4 HINGE-CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-1 (GPC1) FOR TREATING SOLID TUMORS EP National Stage 21762956.7 Pending
NCI E-165-2020-0-KR-01 HLA Class-II Restricted DRB T-cell Receptors Against The RASG12D Mutation KR National Stage 2023-7004523 Pending
NCI E-107-2020-0-US-02 IGG4 HINGE-CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-1 (GPC1) FOR TREATING SOLID TUMORS US National Stage 18/020,191 Pending
NCI E-028-2015-1-AU-01 Anti-Mutated Kras T Cell Receptors AU DIV 2023200614 Pending
NIAID E-279-2016-1-US-11 HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE US CON 18/164,988 Pending
NIA E-249-2016-0-JP-01 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM JP DIV 2023-16292 Pending
NCI E-176-2014-0-AU-01 Anti-Human Papillomavirus 16 E7 T Cell Receptors AU DIV 2023200608 Pending
NEI E-004-2017-0-JP-01 3D VASCULARIZED HUMAN OCULAR TISSUE FOR CELL THERAPY AND DRUG DISCOVERY JP DIV 2023-015034 Issued
NICHD E-185-2020-0-US-03 Multidimensional MRI Signature For Specific Detection Of Traumatic Brain Injury In Vivo US National Stage 18/019,725 Pending
NCI E-165-2020-0-AU-01 HLA Class-II Restricted DRB T-cell Receptors Against The RASG12D Mutation AU National Stage 2021310213 Pending
NINDS E-074-2023-0-US-01 Methods of Diagnosing and Treating Multiple Sclerosis US 63/482,714 Expired
NEI E-005-2023-0-US-01 Deep Learning to Detect Retinal Vasculitis on Color Fundus Photos of Patients with Uveitis US 63/482,676 Expired
NIAID E-241-2014-0-US-02 RECOMBINANT HUMAN/BOVINE PARAINFLUENZA VIRUS 1 (HPIV1) EXPRESSING A CHIMERIC RSV/HPIV1 F PROTEIN AND USES THEREOF US CON 18/162,530 12018051 Issued PDF
NCATS E-218-2021-0-PC-01 SMALL MOLECULE AGONISTS OF THE INSULIN-LIKE 3 (INSL3) PEPTIDE RECEPTOR RXFP2 AND METHODS OF USE THEREOF PCT PCT PCT/US2023/012013 Expired
NCATS E-232-2020-0-US-02 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF US National Stage 18/018,742 Pending
NCI E-196-2018-0-US-02 INSERT FOR PREPARING CELL CULTURE CHAMBERS US National Stage 18/018,762 Pending